insights_auto
Pse është ulur 524494 3,51%?
Zhytu më thellëchevron_right
524494:BOM
IPCA Laboratories Ltd
1 845,00 ₹
arrow_downward
-3,51%(-67,20) 1D
16 tet, 3:30:00 m.d., GMT+5:30 · INR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 524494...
Hap
1 913,95 ₹
I lartë
1 913,95 ₹
I ulët
1 812,60 ₹
Kapitalizimi i tregut
468,21Â mld
Vëllimi mesatar
27,90 mijë
Vëllimi
12,00 mijë
Dividendi
0,33%
Dividendi tremujor
1,50 ₹
Data e ndërprerjes së dividendit
7 gush 2026
Raporti çmim/fitim
35,74
Maksimumi 52-javor
2 039,30 ₹
Minimumi 52-javor
1 252,95 ₹
Fitimet për aksion
51,63 ₹
Aksionet në qarkullim
126,35Â mln
Numri i punonjësve
17 mijë
Hap
1 913,95 ₹
I lartë
1 913,95 ₹
I ulët
1 812,60 ₹
Kapitalizimi i tregut
468,21Â mld
Vëllimi mesatar
27,90 mijë
Vëllimi
12,00 mijë
Dividendi
0,33%
Dividendi tremujor
1,50 ₹
Data e ndërprerjes së dividendit
7 gush 2026
Raporti çmim/fitim
35,74
Maksimumi 52-javor
2 039,30 ₹
Minimumi 52-javor
1 252,95 ₹
Fitimet për aksion
51,63 ₹
Aksionet në qarkullim
126,35Â mln
Numri i punonjësve
17 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Stock Traders Daily
·
4 orë më parë
Understanding Momentum Shifts in (AGIX)
MarketBeat
·
22 minuta më parë
Scholastic (NASDAQ:SCHL) Raised to Hold at Wall Street Zen
Yahoo Finance
·
59 minuta më parë
The S&P 500's "Average" Year Almost Never Happens. Here's How Often It Actually Lands Near 10%.
MarketWatch
·
1 ditë më parë
Don’t buy this dip: Several signs suggest there’s more pain ahead for tech stocks
Profili
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Rreth IPCA Laboratories Ltd